Sign In
Buy ITGR
$90.89
+0.580 (+0.642%)
At Close: Jun 03, 2026
Integer Holdings Stock: The Risk-Reward Is Not On Your Side
01:02pm, Thursday, 11'th May 2023
Integer Holdings Corporation is a $2.6-billion market cap developer and manufacturer of medical devices and components. In Q1 FY2023, the company achieved double-digit sales growth in all four product
Integer Holdings (ITGR) Q1 Earnings, Revenues Beat Estimates
01:39pm, Friday, 28'th Apr 2023
Integer Holdings' (ITGR) first-quarter results reflect robust Medical and Non-Medical sales, besides strength in all the product lines.
3 Reasons to Retain Integer Holdings (ITGR) Stock for Now
12:56pm, Wednesday, 05'th Apr 2023
Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and a solid foothold in the broader MedTech space.
Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023
08:00am, Thursday, 30'th Mar 2023
PLANO, Texas, March 30, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2023, at 7 a.m. C
Integer Holdings: Equity Risk Premium Not Justified, Rate Hold
10:17pm, Sunday, 26'th Feb 2023
Integer Holdings posted growth across all core segments and vertically throughout the P&L. Aspirations for increasing operating leverage to 2x into the coming periods.
Integer Holdings (ITGR) Q4 Earnings Beat Estimates, Margins Up
09:47am, Monday, 20'th Feb 2023
Integer Holdings' (ITGR) fourth-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.
Integer Holdings Corporation (ITGR) Q4 2022 Earnings Call Transcript
11:45pm, Saturday, 18'th Feb 2023
Integer Holdings Corporation (NYSE:ITGR ) Q4 2022 Earnings Conference Call February 16, 2023 9:00 AM ET Company Participants Tony Borowicz - Senior Vice President of Investor Relations Joe Dziedzic -
Integer Holdings Corporation (ITGR) Q3 2022 Earnings Call Transcript
08:52am, Saturday, 29'th Oct 2022
Integer Holdings Corporation (NYSE:ITGR ) Q3 2022 Earnings Conference Call October 27, 2022 9:00 AM ET Company Participants Anthony Borowicz - Senior Vice President, Investor Relations Joe Dziedzic -
Integer Holdings (ITGR) Q3 Earnings Beat, 2022 View Lowered
02:18pm, Friday, 28'th Oct 2022
Integer Holdings' (ITGR) third-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.
Here's Why You Should Retain Integer Holdings (ITGR) Stock Now
12:02pm, Tuesday, 27'th Sep 2022
Integer Holdings (ITGR) continues to gain momentum from robust medical sales and a solid foothold in the broader MedTech space. However, intense competition persists.
Integer Holdings Corporation (ITGR) CEO Joe Dziedzic on Q2 2022 Results - Earnings Call Transcript
10:15am, Sunday, 31'st Jul 2022
Integer Holdings Corporation (NYSE:ITGR ) Q2 2022 Earnings Conference Call July 28, 2022 12:00 PM ET Company Participants Tony Borowicz - Senior Vice President, Investor Relations Joe Dziedzic - Presi
Integer (ITGR) Q2 Earnings Miss Estimates
10:57am, Thursday, 28'th Jul 2022
Integer (ITGR) delivered earnings and revenue surprises of -11.86% and 1.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Integer Holdings (ITGR) Stock Now
11:44am, Thursday, 30'th Jun 2022
Integer Holdings (ITGR) continues to gain momentum from improving non-medical sales and a solid foothold in the broader MedTech space. However, intense competition persists.
Integer Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022
08:00am, Thursday, 30'th Jun 2022
PLANO, Texas, June 30, 2022 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2022, at 7 a.m. C
Reasons to Retain Integer Holdings (ITGR) Stock For Now
12:48pm, Tuesday, 31'st May 2022
Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and solid foothold in the broader MedTech space.
